A Study to Look at How Safe NNC0472-0147 is in Healthy People and in People With Type 2 Diabetes

NCT04262661 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Diabetes Mellitus, Type 2

Interventions

DRUG: NNC0472-0147
DRUG: insulin glargine
DRUG: Placebo (NNC0472-0147)

Sponsor

Novo Nordisk A/S